Atherosclerosis
Merck/Schering-Plough Pharmaceuticals Comments on Results of the ENHANCE Study
Published in Medical Device Business Week, April 16th, 2008
Results of ENHANCE (Ezetimibe aNd simvastatin in Hypercholesterolemia enhANces atherosClerosis rEgression), an imaging trial in 720 patients with heterozygous familial hypercholesterolemia (HeFH), a rare genetic condition that causes very high levels of LDL "bad" cholesterol and greatly increases the risk for premature coronary artery disease, were presented at the 57th annual scientific sessions of the American College of Cardiology and also were published on-line in The New England Journal of Medicine(i).
As previously reported on Jan. 14, 2008, despite the fact that ezetimibe/simvastatin 10/80 mg (VYTORIN(R) *) significantly lowered LDL "bad" cholesterol more than...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- ACIST Medical Systems, Inc.
ACIST Medical Systems Enhances Portfolio with Acquisition of E-Z-EM Products and Systems - Anxiety Disorders
Cortex Initiates Enrollment in Opiate Induced Respiratory Depression Clinical Trial in Germany Today - Asthma
Angeion Corporation Introduces the Medical Graphics Platinum Elite(TM) Series Plethysmograph for Pulmonary Function Testing - ATEK Medical
ATEK Opens Medical Device Manufacturing Facility in Costa Rica - Biliary Stents
Off-Label Stent Use: How Important Are FDA Approvals to Physicians? - Bone Research
Manhattan Scientifics Signs Letter of Intent to Acquire Metallicum, Inc. - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
